During the past decade, Hospital Regional de Veracruz conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Regional de Veracruz" #1 collaborator was "Eisai Europe Ltd. (United Kingdom)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Regional de Veracruz" are "Caloric Deficit" (1 trials), "Malnutrition" (1 trials), "Nutritional Status" (1 trials) and "Ovarian Cancer" (1 trials). Many other conditions were trialed in "Hospital Regional de Veracruz" in a lesser frequency.

Most popular intervention types in "Hospital Regional de Veracruz" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (1 trials), "Farletuzumab" (1 trials), "Farletuzumab-matched placebo" (1 trials) and "Taxane" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Regional de Veracruz" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Regional de Veracruz". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Hospital Regional de Veracruz, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Regional de Veracruz, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".